Lara Smith
Impact in
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Genetics top 5%
- Genetic Associations and Epidemiology
Papers in
- Genetics 7
- Genetic Associations and Epidemiology 6
- Genetic and Kidney Cyst Diseases 1
-
- COVID-19 Clinical Research Studies 5
- SARS-CoV-2 and COVID-19 Research 2
- Journals
- Nature (4 papers)The Lancet (3 papers)European Respiratory Journal (1 paper)Med (1 paper)Human Genetics and Genomics Advances (1 paper)
- Partner nations
- United Kingdom
In The Last Decade
Lara Smith
11 papers receiving 1.7k citations
Lara Smith's Hit Papers
Peers
Comparison fields: 5 of 91
- Infectious Diseases 929
- Genetics 515
- Applied Microbiology and Biotechnology 33
- Neurology 144
- Immunology 116
Countries citing papers authored by Lara Smith
This map shows the geographic impact of Lara Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lara Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lara Smith more than expected).
Fields of papers citing papers by Lara Smith
This network shows the impact of papers produced by Lara Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lara Smith. The network helps show where Lara Smith may publish in the future.
No co-authors to show.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Mapping the human genetic architecture of COVID-19 Hit paper breakdown → | 2021 | 656 |
| 2 | Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 411 |
| 3 | Whole-genome sequencing reveals host factors underlying critical COVID-19 Hit paper breakdown → | 2022 | 233 |
| 4 | 2021 | 126 | |
| 5 | GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19 Hit paper breakdown → | 2023 | 125 |
| 6 | 2022 | 71 | |
| 7 | 2023 | 60 | |
| 8 | 2024 | 56 | |
| 9 | 2023 | 35 | |
| 10 | 2024 | 8 | |
| 11 | 2024 | 5 | |
| 12 | 2021 | 0 |
About Lara Smith
Lara Smith is a scholar working on Genetics, Infectious Diseases, Nephrology, Neurology and Surgery, having authored 12 papers that have together received 1.8k indexed citations. Recurring topics across this work include Genetic Associations and Epidemiology (6 papers), COVID-19 Clinical Research Studies (5 papers), Dialysis and Renal Disease Management (2 papers), Chronic Kidney Disease and Diabetes (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Knee injuries and reconstruction techniques (1 paper), Genetic and Kidney Cyst Diseases (1 paper) and Long-Term Effects of COVID-19 (1 paper). The work is most often cited by research in Infectious Diseases (929 citations), Genetics (515 citations), Applied Microbiology and Biotechnology (33 citations), Neurology (144 citations) and Immunology (116 citations). Lara Smith has collaborated with scholars based in United Kingdom. Their work appears in journals such as Nature, The Lancet, European Respiratory Journal, Med and Human Genetics and Genomics Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.